Paxil (Paroxetine HCl) Patent Expiration, LOE Window & CMS Spending

Paxil (Paroxetine HCl) by Apotex: Off-Patent Genericized (AB Competition), 12 AB generics, $1.9M 2024 CMS Part D & Medicaid spend, and 21 CA HCAI SB 17 wholesale price filings.

Regulatory & Reimbursement Dimension Verified Value
Consolidated SponsorApotex
FDA Application & PathwayN020031 (NDA)
Exclusivity / Cliff HorizonOff-Patent Genericized (AB Competition)
Core Active-Ingredient LOE DateNot listed / N/A
Last Listed Patent or Exclusivity DateNot listed / N/A
Orange Book Patents (*PED Extensions)0 patents (0 *PED)
Active AB-Rated Generic Competitors12
2024 CMS Total Public Spend$1.9M
2024 Medicare Part D Spend$1.7M
2024 Medicaid Spend$231K
Reported Wholesale Price Change (CA SB 17)21 WAC filings (max 59.9% 2-yr change)